This phase II trial studies the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated pancreatic neuroendocrine tumors. Chemotherapy drugs, such as capecitabine and temozolomide, work in…
- Investigator
- Brian H Ramnaraign
- Ages
- 18 Years - N/A
- Sexes
- All